Avigen, Inc. Announces Second Quarter 2008 Earnings Conference Call

Avigen to host conference call Wednesday, July 30, at 1:00 p.m. ET

ALAMEDA, Calif., July 22 /PRNewswire-FirstCall/ -- Avigen, Inc.
(Nasdaq: AVGN), a biopharmaceutical company innovating therapeutics for
neurological care, will hold its quarterly conference call to discuss second
quarter results on Wednesday, July 30, 2008, at 1:00 p.m. ET (10:00 a.m. PT).
Kenneth Chahine, Chief Executive Officer, and Michael Coffee, Chief Business
Officer, can be heard by calling 800-299-6183 (U.S.) or 617-801-9713 (non-U.S.
locations) using passcode 82752952.
This call is being webcast by Thomson/CCBN and can be accessed at Avigen's
website at www.avigen.com. The webcast is also being distributed through the
Thomson StreetEvents Network. Individual investors can listen to the call at
www.earnings.com, Thomson's individual investor portal, powered by
StreetEvents. Institutional investors can access the call via Thomson
StreetEvents (www.streetevents.com), a password-protected event management
site.
A rebroadcast of the call will be available shortly after the conclusion
of the session. The replay may be accessed over the Internet at www.avigen.com
or by calling 888-286-8010 (U.S.) or 617-801-6888 (non-U.S. locations) using
passcode 68258121.
About Avigen
Avigen is a biopharmaceutical company focused on developing and
commercializing small molecule therapeutics to treat serious neurological
disorders, including neuropathic pain and neuromuscular spasm and spasticity.
For press releases and other corporate information, visit our website at
www.avigen.com.
SOURCE Avigen, Inc.

Michael Coffee, Chief Business Officer of Avigen, Inc., +1-510-748-7372,
ir@avigen.com